Drug Type Small molecule drug |
Synonyms- |
Target |
Action inhibitors |
Mechanism Raf kinase inhibitors(RAF serine/threonine protein kinase inhibitors) |
Therapeutic Areas |
Active Indication- |
Inactive Indication |
Originator Organization |
Active Organization- |
Inactive Organization |
License Organization- |
Drug Highest PhasePendingPreclinical |
First Approval Date- |
Regulation- |
| Indication | Highest Phase | Country/Location | Organization | Date |
|---|---|---|---|---|
| BRAF V600E mutant Colorectal Cancer | Preclinical | United Kingdom | 01 Jul 2017 | |
| BRAF V600E mutant Colorectal Cancer | Preclinical | United Kingdom | 01 Jul 2017 | |
| Melanoma | Preclinical | United Kingdom | 01 Jul 2017 | |
| Melanoma | Preclinical | United Kingdom | 01 Jul 2017 | |
| Non-Small Cell Lung Cancer | Preclinical | United Kingdom | 01 Jul 2017 | |
| Non-Small Cell Lung Cancer | Preclinical | United Kingdom | 01 Jul 2017 |





